Cargando…

Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses

Background. Invasive fungal diseases (IFD) caused by Cryptococcus and dimorphic fungi are associated with significant morbidity and mortality. Isavuconazole (ISAV) is a novel, broad-spectrum, triazole antifungal agent (IV and by mouth [PO]) developed for the treatment of IFD. It displays potent acti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thompson, George R., Rendon, Adrian, Ribeiro dos Santos, Rodrigo, Queiroz-Telles, Flavio, Ostrosky-Zeichner, Luis, Azie, Nkechi, Maher, Rochelle, Lee, Misun, Kovanda, Laura, Engelhardt, Marc, Vazquez, Jose A., Cornely, Oliver A., Perfect, John R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Articles and Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946023/ https://www.ncbi.nlm.nih.gov/pubmed/27169478 http://dx.doi.org/10.1093/cid/ciw305

Ejemplares similares

824 An Open-Label Phase 3 Study of Isavuconazole (VITAL): Focus on Mucormycosis
por: Marty, Francisco M., et al.
Publicado: (2014)

Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trial
por: Perfect, John R., et al.
Publicado: (2018)

Implantation mycoses. An unsolved problem
por: Queiroz-Telles, Flavio, et al.
Publicado: (2022)

Isavuconazole: Mechanism of Action, Clinical Efficacy, and Resistance
por: Ellsworth, Misti, et al.
Publicado: (2020)

Endemic and Other Dimorphic Mycoses in The Americas
por: Lockhart, Shawn R., et al.
Publicado: (2021)

Post-exposure prophylaxis with isavuconazole after occupational exposure to Rhizopus
por: Al-Obaidi, Mohanad, et al.
Publicado: (2018)

Cryptococcosis
por: Maziarz, Eileen K., et al.
Publicado: (2014)

Cost-Effectiveness Analysis of Isavuconazole vs. Voriconazole as First-Line Treatment for Invasive Aspergillosis
por: Harrington, Rachel, et al.
Publicado: (2016)

Pharmacodynamics of Isavuconazole in a Rabbit Model of Cryptococcal Meningoencephalitis
por: Kovanda, Laura L., et al.
Publicado: (2019)

A Mycoses Study Group International Prospective Study of Phaeohyphomycosis: An Analysis of 99 Proven/Probable Cases
por: Revankar, Sanjay G, et al.
Publicado: (2017)

Management of Cryptococcosis: How Are We Doing?
por: Perfect, John R
Publicado: (2007)

1210 A Phase 3, Randomized, Double-Blind, Non-inferiority Trial to Evaluate Efficacy and Safety of Isavuconazole versus Voriconazole in Patients with Invasive Mold Disease (SECURE): Outcomes in Neutropenic Patients
por: Patterson, Thomas, et al.
Publicado: (2014)

Impact of Mucositis on Absorption and Systemic Drug Exposure of Isavuconazole
por: Kovanda, Laura L., et al.
Publicado: (2017)

Pharmacodynamics of Isavuconazole for Invasive Mold Disease: Role of Galactomannan for Real-Time Monitoring of Therapeutic Response
por: Kovanda, Laura L., et al.
Publicado: (2017)

The war on cryptococcosis: A Review of the antifungal arsenal
por: Mourad, Ahmad, et al.
Publicado: (2018)

The Triple Threat of Cryptococcosis: It’s the Body Site, the Strain, and/or the Host
por: Perfect, John R.
Publicado: (2012)

2537. Population Pharmacokinetics of Isavuconazole in Pediatric Patients
por: Desai, Amit, et al.
Publicado: (2023)

Systemic Mycoses
por: Andriole, Vincent T.
Publicado: (1969)

The Mycoses of the Spleen
Publicado: (1930)

Post-hoc analysis of the safety and efficacy of isavuconazole in older patients with invasive fungal disease from the VITAL and SECURE studies
por: Hamed, Kamal, et al.
Publicado: (2023)

1149. Baseline Chest CT Findings in Patients with Pulmonary Mold Infections: A Post-Hoc Analysis from the Phase 3 SECURE Study that Compared Isavuconazole to Voriconazole for the Primary Treatment of Invasive Mold Disease
por: Hamed, Kamal, et al.
Publicado: (2020)

The era of histoplasmosis in Brazilian endemic mycoses
por: Falci, Diego R., et al.
Publicado: (2021)

Identification of Mycoses in Developing Countries
por: Arastehfar, Amir, et al.
Publicado: (2019)

Immunologic Diagnosis of Endemic Mycoses
por: Almeida-Paes, Rodrigo, et al.
Publicado: (2022)

Molecular Diagnosis of Endemic Mycoses
por: Valero, Clara, et al.
Publicado: (2022)

825 A Phase 3, Randomized, Double-Blind, Non-Inferiority Trial to Evaluate Efficacy and Safety of Isavuconazole vs Voriconazole in Patients with Invasive Mold Disease (IMD): Outcomes in Patients with Pulmonary Infections
por: Raad, Issam, et al.
Publicado: (2014)

Re-drawing the Maps for Endemic Mycoses
por: Ashraf, Nida, et al.
Publicado: (2020)

Disseminated Cryptococcosis With Brain Involvement in Patients With Chronic Lymphoid Malignancies on Ibrutinib
por: Messina, Julia A., et al.
Publicado: (2017)

Efficacy and Associated Drug Exposures of Isavuconazole and Fluconazole in an Experimental Model of Coccidioidomycosis
por: Kovanda, Laura L., et al.
Publicado: (2021)

Isavuconazole for the treatment of patients with invasive fungal diseases involving the central nervous system
por: Schwartz, Stefan, et al.
Publicado: (2020)

Proceedings of the third international conference on the mycoses

Proceedings of the VI internacional conference on the mycoses

Superficial Mycoses Associated with Diaper Dermatitis
por: Bonifaz, Alexandro, et al.
Publicado: (2016)

Mycoses, with Special Reference to Mycosis of the Eyeball
por: Buchanan, Leslie
Publicado: (1904)

Therapy of Non-Dermatophytic Mycoses in Animals
por: Elad, Daniel
Publicado: (2018)

Advances in the Treatment of Mycoses in Pediatric Patients
por: Iosifidis, Elias, et al.
Publicado: (2018)

Climate drivers of hospitalizations for mycoses in Brazil
por: Silva, Fabrício Brito, et al.
Publicado: (2019)

Orbital mycoses in an adult subtropical population
por: Lee, Allister S., et al.
Publicado: (2019)

Chest Imaging in Systemic Endemic Mycoses
por: Sousa, Célia, et al.
Publicado: (2022)

Endemic Mycoses: Novel Findings for the Clinician
por: Pasqualotto, Alessandro C.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9cprjnttod15pp1pa9vuas3u0u